Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
Increasing focus on developing biologics such as monoclonal antibodies (mAbs) for therapeutic purposes The demand for monoclonal antibody therapies is increasing rapidly owing to their high specificity and ability to treat various chronic and life-threatening diseases
Acknowledgements This work is supported by the NSF-CREST Grant number HRD 1036494 and HRD 1547771, and NSF-IGERT
We show that MYC attenuates GCLC via miR18a in a mouse model of liver cancer, contributing to GSH depletion and sensitivity to oxidative stress
No bad odor was going to stop me from my 20-minute high intensity cardio session
doi: 10.1016/j.biopha.2015.07.034, 56
US$ 29.96
US$ 27.32
US$ 27.76
US$ 23.12
US$ 24.68
US$ 26.40
US$ 27.74
US$ 20.31
